PLAKOUS THERAPEUTICS
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
PLAKOUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Winston Salem, North Carolina, United States
Country:
United States
Website Url:
http://www.plakoustherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
336-782-3106
Email Addresses:
[email protected]
Total Funding:
3.66 M USD
Technology used in webpage:
COVID-19 Fastly Hosted
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Cidara Therapeutics
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
Altis Biosystems
Altis Biosystems investment in Grant - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Plakous Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Plakous Therapeutics
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - Plakous Therapeutics
Official Site Inspections
http://www.plakoustherapeutics.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plakous Therapeutics"
Plakous Therapeutics - Crunchbase Company Profile & Funding
Organization. Plakous Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Leadership - Plakous Therapeutics
Michael Berger, PhD is Senior Product Development Engineer at Plakous. He earned his BS and PhD in biomedical engineering from Virginia Commonwealth University focusing on stem cell …See details»
Plakous Therapeutics - LinkedIn
Plakous Therapeutics | 370 followers on LinkedIn. Healing After Birth. Developing cell free, placenta powered bio-therapeutics to drive in-situ regenerative healing.See details»
Plakous Therapeutics - PitchBook
Www.plakoustherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 755 Highland …See details»
Board of Directors - Plakous Therapeutics
Stay Informed. Join our mailing list to keep up to date on new developments and progress.See details»
Plakous Therapeutics - Org Chart, Teams, Culture
View Plakous Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Plakous Therapeutics LLC - VentureRadar
Website: http://www.plakoustherapeutics.com. Plakous Therapeutics is developing biotherapeutics from post-delivery placenta to promote regenerative healing for ...See details»
PLAKOUS THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PLAKOUS THERAPEUTICS, INC. of Pfafftown, NC. Get the latest business insights from Dun & Bradstreet.See details»
Plakous Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Plakous Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature, Technology Platform:Biological products ...See details»
Plakous Therapeutics | Seed
Plakous Therapeutics developed a patented platform biotherapeutic to prevent the rare pediatric disease, necrotizing enterocolitis, and a follow-on indication for osteoarthritis.See details»
Plakous Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 755 Highland Oaks Drive Suite 103. Winston Salem, North Carolina, 27103, United States. 336-782-3106See details»
Plakous Therapeutics | CipherBio
Explore Plakous Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Plakous Therapeutics - Overview, News & Similar companies
Plakous Therapeutics Awarded Phase II SBIR Grant from NIH to Continue Development of Therapies for Necrotizing Enterocolitis WINSTON-SALEM, N.C., Aug. 10, 2021 /PRNewswire/ …See details»
Contact Us - Plakous Therapeutics
Contact Us Our expert team can help answer any questions you may have. Get in touch today to learn more about Plakous Therapeutics.See details»
Plakous Therapeutics Inc. | North Carolina Biotech Center
Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti …See details»
Plakous Therapeutics Announces New Funding to Support …
WINSTON-SALEM, N.C., July 5, 2022 /PRNewswire/ -- Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina …See details»
Behind Our Science - Plakous Therapeutics
Necrotizing Enterocolitis. Our first clinical target is preventing necrotizing enterocolitis (NEC), a rare pediatric disease complicated by prematurity that affects 6.2% of the 52,000 premature …See details»
Novartis to acquire Regulus Therapeutics and farabursen, an ...
4 days ago Patient organization funding Payments to healthcare professionals Public policy A living wage A safe workplace Animal research Environmental, social and governance. Learn …See details»
News - Plakous Therapeutics
FDA Designations. Plakous Therapeutics, Inc. has been granted orphan drug and rare pediatric disease designations for its human placental extract, Protego-PDTM for the prevention of …See details»
Lykos Therapeutics - Wikipedia
Lykos Therapeutics, formerly known as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use. [1] …See details»